Reference
Thomas G. A cost-benefit analysis of the immunisation of children against respiratory syncytial virus (RSV) using the English Hospital Episode Statistics (HES) data set. European Journal of Health Economics : 04 Jan 2015. Available from: URL: http://dx.doi.org/10.1007/s10198-014-0662-9
Rights and permissions
About this article
Cite this article
RSV immunisation in high-risk children good value for money. PharmacoEcon Outcomes News 720, 30 (2015). https://doi.org/10.1007/s40274-015-1869-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1869-4